drugset / Trial / NCT02187068
Dexmedetomidine Pharmacokinetics in the Obese
RandomizedSingle-groupQuadruple-blindSupportive care
Summary
The aim of this study is to characterize, using two different modeling approaches, one based on purely statistic concept and one using a more mechanistic analysis, the influence of body weight and composition on the pharmacokinetic of dexmedetomidine.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-12
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.25 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |